Prediction of Coronary Heart Disease Risk in HIV‐Infected Patients with Fat Redistribution
Open Access
- 1 April 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (7) , 909-916
- https://doi.org/10.1086/368185
Abstract
A metabolic syndrome has been described among human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy; thKeywords
This publication has 27 references indexed in Scilit:
- Modifiable Dietary Habits and Their Relation to Metabolic Abnormalities in Men and Women with Human Immunodeficiency Virus Infection and Fat RedistributionClinical Infectious Diseases, 2001
- Increased PAI-1 and tPA Antigen Levels Are Reduced with Metformin Therapy in HIV-Infected Patients with Fat Redistribution and Insulin ResistanceJournal of Clinical Endocrinology & Metabolism, 2001
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Metformin in the Treatment of HIV Lipodystrophy SyndromeJAMA, 2000
- The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor TherapyJournal of Biological Chemistry, 2000
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart DiseaseNew England Journal of Medicine, 1996
- Glucose tolerance and the risk of cardiovascular diseases: The zutphen studyJournal of Clinical Epidemiology, 1992
- Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.BMJ, 1984
- AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIESAmerican Journal of Epidemiology, 1979